Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
https://twitter.com/Belcourtoi/status/1328705601170444290?s=20
https://twitter.com/NaPoM2021/status/1328063537785266178?s=20
https://twitter.com/cigahealthcare/status/1327236601932632068?s=20
https://twitter.com/cigahealthcare/status/1327236601932632068?s=20
https://twitter.com/QasimAl22359016/status/1327187646372843521?s=20
https://twitter.com/Belcourtoi/status/1326920142354329601?s=20
https://www.sciencemediacentre.org/expert-reaction-to-study-evaluating-the-accuracy-of-the-abc-19tm-rapid-test-for-sars-cov-2-antibodies/?cli_action=1605183766.998
“Antibody tests remain the best way to assess population levels of infection, but we do know levels of antibody can change with time. Again, this type of data measuring antibody test accuracy is essential to guide use in population surveys. Rapid tests still offer a very convenient format for testing, but may not pick up as many positive samples as laboratory tests.
“One interesting data set presented is the comparison of antibody detected against two viral components (S and N). Measuring antibody against both of these remains important yet laborious, so the more data we have the better, to see if any differences in protection or disease severity emerge.
“However, these new data are very useful at a public health level. If we know how many cases the test is missing, and how many it is wrongly calling positive, we can adjust our population estimates of prior infection accordingly. As a public health tool, these low-tech, easily deployed and rapid tests could have an important role to play in mapping the pandemic globally as well as in the UK.”
“None of this means the test is useless, by any means. After all, if all we know about a person is that they come from a group where 10% have antibodies, then we’d assess their chance of having antibodies as 10%. If they are then tested with this test, and tested positive, we’d know that their chance of having antibodies is about 80%, so we’ve learned a lot about them. (If they tested negative, their chance of not having antibodies would be about 99%, whereas before the test it was considerably less, 90%, so the test result is still quite informative.)
https://www.gov.uk/government/publications/coronavirus-covid-19-testing-privacy-information/antibody-testing-for-coronavirus-privacy-information
Annex 1: types of antibody tests
There is currently one type of antibody test available to see if you have had coronavirus. This is the ELISA Test.
This test requires a sample of blood. More details can be found below.
ELISA Test
This test can be conducted at home (or other non-hospital environment) and requires you to take your own sample of blood. The home test kit contains all you need to take your test at home, as well as instructions on how to take the test.
This sample is then sent to a pathology laboratory for analysis. Once the results are known, you will be informed of the result.
https://unfoldtimes.com/this-finger-prick-covid-19-test-kit-could-cost-as-little-as-1/
the government is desperate for accurate fast LFT
Additional partner laboratories across the UK and internationally were considered, however were deemed inappropriate for reasons including but not limited to; limited available capacity, testing protocol and inability to meet required sample turnaround times.
https://bidstats.uk/tenders/2020/W46/738590800
https://twitter.com/seangill7/status/1325858796053422080?s=20
https://www.rfcambrian.com/index.php/services/brr-media-webcasts/
PE of CD4/HIV and food intolerance alone already far exceeds current SP
The high demand for tests has put the diagnostics test manufacturing industry under immense pressure. The sudden global need for accurate, high-quality testing is unlike anything it has experienced before. According to a report by Barron's, "To meet growing global demand, current test manufacturers and their supply chains need to continue investing to scale up production. That alone won't be enough. More companies need to start manufacturing tests. In the U.S. only a few companies have been granted FDA Emergency Use Authorization to sell rapid diagnostic tests, and most of these tests are manufactured offshore. Transferring the manufacturing technology for these high-quality tests to the U.S. and building up local manufacturing facilities would quickly increase the supply."
https://www.prnewswire.co.uk/news-releases/demand-for-effective-diagnostics-surges-alongside-a-new-wave-833490901.html
Introdent is currently operational on a restricted basis. Our priority is to distribute the VISITECT® COVID 19 IgM-IgA-IgG. Our parent company, Dental Life Sciences Ltd, has an exclusive distribution agreement to distribute this antibody test and subsequent saliva based antigen tests to UK dentistry. Omega are a British company who are part of the UK-Rapid Test Consortium set up by the Department of Health and Social Care to ensure supplies of high accuracy diagnostic tests are available to HMG. The tests are researched, designed and manufactured in the U.K. as part of the U.K.’s efforts to meet the global Challenges we are experiencing.
To read more about VISITECT® COVID 19 IgM-IgA-IgG – Rapid Diagnostic Test click here.
https://www.introdent.com/shop/visitect-covid-19-igm-iga-igg-rapid-diagnostic-test/